To access this element change to forms mode OFF
Grant Award View - GA201607
Phage Therapy - a novel solution for difficult-to-treat infections in...
GA ID:
GA201607
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$570,592.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Phage Therapy - a novel solution for difficult-to-treat infections in children
Purpose:
Phages are viruses that kill bacteria and offer a novel solution to treat infections, including antibiotic-resistant ones. This research aims to develop phage therapy as a treatment option for difficult-to-treat infections in children. It will combine the latest advances in bacterial genomics, rapid phage-bacteria matching and clinical trial methods to assess the value of phage therapy to treat serious infections in children with cystic fibrosis and other chronic debilitating infections.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2008024
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA